Nolvadex (Tamoxifen Citrate)

Nolvadex (tamoxifen citrate) acts on estrogen‑dependent pathways in breast tissue and is indicated for several oncologic indications.

• Estrogen receptor‑positive breast cancer (adjuvant therapy): reduces the risk of disease recurrence after surgery.
• Metastatic breast cancer: slows disease progression and may extend survival.
• Prevention of breast cancer in high‑risk women: lowers the incidence of new breast tumours in women with elevated risk.

• Tamoxifen citrate binds competitively to estrogen receptors in breast tissue, acting as an antagonist that blocks estrogen‑driven transcriptional activity. By preventing estrogen from stimulating cell proliferation, it inhibits tumor growth and reduces the likelihood of new estrogen‑dependent lesions forming.

Tamoxifen citrate may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects

• Hot flashes: sudden feeling of warmth, often with sweating.
• Nausea: mild to moderate upset stomach.
• Fatigue: persistent tiredness.
• Menstrual irregularities: changes in cycle length or flow.
• Vaginal dryness: reduced lubrication.
• Headache: mild to moderate pain.

Serious or Rare Side Effects

• Thromboembolic events: deep‑vein thrombosis or pulmonary embolism.
• Endometrial cancer: abnormal uterine bleeding may signal malignancy.
• Liver function abnormalities: elevated enzymes or hepatitis.
• Severe allergic reactions: rash, swelling, or anaphylaxis.
• Vision changes: blurred vision or retinal disorders.
• Pulmonary embolism: sudden shortness of breath and chest pain.

Before initiating therapy, clinicians should evaluate individual risk factors and monitor patients regularly.

• Liver function monitoring: assess baseline enzymes and repeat during treatment.
• Thromboembolic risk assessment: screen for history of clotting disorders.
• Menstrual changes: counsel patients about possible cycle alterations.
• Contraception advice: recommend effective methods during treatment.
• Pregnancy avoidance: drug is contraindicated in pregnancy.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Tamoxifen citrate can interact with several drug classes, influencing efficacy or safety.

Major Interactions (Avoid)

• Strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine): reduce tamoxifen activation.
• Warfarin: may increase anticoagulant effect and INR.
• Hormonal contraceptives: potential reduction in contraceptive efficacy.
• SSRIs with CYP2D6 activity: may diminish therapeutic benefit.
• St. John’s wort: induces metabolism, lowering plasma levels.

Moderate Interactions (Monitor Closely)

• Other anticoagulants: monitor coagulation parameters.
• CYP3A4 inducers (e.g., rifampin): may decrease drug exposure.
• Antifungal agents (e.g., ketoconazole): can raise tamoxifen concentrations.
• Certain antidepressants: observe for additive side effects.
• Herbal supplements (e.g., ginkgo): assess for bleeding risk.